Melinta Therapeutics, INC. /NEW/
SEC CIK 1461993 · MLNT · last insider filing 2019-10-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sanfilippo Jennifer A | Director · interim Chief Executive Office | filed 2019 - 2019 |
| Johnson John H | Director · Interim CEO | filed 2012 - 2019 |
| Gill David N | Director | filed 2012 - 2019 |
| Downey Bruce | Director | filed 2018 - 2019 |
| Ferro Kevin | Director | filed 2017 - 2019 |
| Koestler Thomas P | Director | filed 2017 - 2019 |
| Zaccardelli David | Director · Acting Chief Executive Officer | filed 2016 - 2019 |
| Galeota James JR | Director | filed 2017 - 2019 |
| Vatera Healthcare Partners LLC | Director | filed 2017 - 2019 |
| Vatera Capital Management LLC | Director | filed 2019 - 2019 |
| Kong Garheng | Director | filed 2012 - 2018 |
| Gonzalo Cecilia | Director | filed 2017 - 2018 |
| Wechsler Daniel Mark | Director · See Remarks | filed 2017 - 2018 |
| Vatera Holdings LLC | Director | filed 2017 - 2018 |
| Goldstein DOV A MD | Director | filed 2012 - 2017 |
| Dougherty Michael R | Director | filed 2013 - 2017 |
| Kent Richard S | Director | filed 2012 - 2017 |
| Neff P Sherrill | Director | filed 2012 - 2016 |
| Fernandes Prabhavathi | Director · President and CEO | filed 2012 - 2016 |
| Morris I Wistar III | Director | filed 2012 - 2012 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lococo Ryan | Chief Operating Officer | filed 2019 - 2019 |
| Blum Susan | VP of Finance & CAO | filed 2019 - 2019 |
| Milligan Peter J | Chief Financial Officer | filed 2018 - 2019 |
| Cammarata Sue | Chief Medical Officer | filed 2017 - 2019 |
| Estrem Paul | Chief Financial Officer | filed 2017 - 2018 |
| Duffy Erin | Chief Scientific Officer | filed 2017 - 2018 |
| Temperato John | Chief Commercial Officer | filed 2017 - 2017 |
| Hahn Mark W | EVP and CFO | filed 2012 - 2017 |
| Moore David | Chief Commercial Officer | filed 2014 - 2017 |
| Oldach David W. | Chief Medical Officer | filed 2015 - 2017 |
| Bluth John D | EVP of Investor Relations | filed 2016 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.